India To Invest $500 Million In Education, Training To Improve Drug Quality
This article was originally published in PharmAsia News
Executive Summary
India plans to tackle compliance problems in the nation's generic-drug industry by investing $500 million to support education and training of workers in the local industry, top officials said.